<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02682394</url>
  </required_header>
  <id_info>
    <org_study_id>SOR0216-15CTIL</org_study_id>
    <nct_id>NCT02682394</nct_id>
  </id_info>
  <brief_title>Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas</brief_title>
  <official_title>Prognostic Importance of Quantitative Magnetic Resonance Imaging for Evaluation of Pancreatic Steatosis in Patients With Pancreatic Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soroka University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Soroka University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prognostic Importance of Quantitative Magnetic Resonance Imaging for Evaluation of Pancreatic
      Steatosis in Patients with Pancreatic Cancer
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Finding patients with pancreatic cancer (in all stages), before any treatment.

        2. Non invasively quantify fatty infiltration of pancreas using, MRI DIXON Scan in
           pancreatic cancer patient relatively to liver.

        3. Measuring cell-free blood DNA in those patients for evaluating the aggressiveness of the
           disease.

        4. Quantify the prognostic significance of pancreatic steatosis in comparison with clinical
           and pathological prognostic indexes used today.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of fat in pancreas measured in the head, body and tail excluding the lesion area.</measure>
    <time_frame>at 24 hours before chemotherapy starting</time_frame>
    <description>measuring Pancreatic Steatosis in patients with pancreatic cancer using MRI DIXON scan, at 24 hours before chemotherapy starting.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood levels of free DNA</measure>
    <time_frame>The blood sample taken 15 minutes prior to MRI study, at time of IV access.</time_frame>
    <description>Correlation of free DNA level and metastatic spread.</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cancer of Pancreas</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cell-free DNA, CFD
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        30 patients diagnosed with any pancreatic cancer, in any stage, before treatment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients diagnosed with any pancreatic cancer, in any stage, before treatment.

          -  &gt;18 y.o

        Exclusion Criteria:

          -  claustrophobia

          -  GFR&lt;30

          -  patients with non mri compatible devices (e.g. orthopaedic external fixation system)

          -  After chemotherapy treatment or surgical procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alla Khashper, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soroka University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vladimir Borodetsky, MD</last_name>
    <phone>+972547428882</phone>
    <email>zivova1982@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Irena Lazerev, MD</last_name>
    <phone>+972526226458</phone>
    <email>irinalaz@clalit.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Soroka university medical center</name>
      <address>
        <city>Beer Sheva</city>
        <zip>=</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir Borodetsky, MD</last_name>
      <phone>+972547428882</phone>
      <email>zivova1982@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Irina Lazerev, MD</last_name>
      <phone>+972526226458</phone>
      <email>irinalaz@clalit.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Alla Khashper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2015</study_first_submitted>
  <study_first_submitted_qc>February 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2016</study_first_posted>
  <last_update_submitted>February 12, 2016</last_update_submitted>
  <last_update_submitted_qc>February 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cancer of pancreas</keyword>
  <keyword>steatosis</keyword>
  <keyword>MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

